1. Fischer, A, du Bois, R. Interstitial lung disease in connective tissue disorders. Lancet 2012; 380: 689–698.
Google Scholar | Crossref | Medline | ISI2. Karakontaki, FV, Panselinas, ES, Polychronopoulos, VS, et al. Targeted therapies in interstitial lung disease secondary to systemic autoimmune rheumatic disease. Autoimmun Rev 2021; 20: 102742.
Google Scholar | Crossref | Medline3. Fischer, A, Antoniou, KM, Brown, KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46: 976–987.
Google Scholar | Crossref | Medline4. Kamiya, H, Panlaqui, OM. Systematic review and meta-analysis of the prognosis and prognostic factors of interstitial pneumonia with autoimmune features. BMJ Open 2019; 9: e031444.
Google Scholar | Crossref5. Spagnolo, P, Distler, O, Ryerson, CJ, et al. Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs). Ann Rheum Dis 2021; 80: 143–150.
Google Scholar | Crossref | Medline6. Wells, AU, Brown, KK, Flaherty, KR, et al. What’s in a name? That which we call IPF, by any other name would act the same. Eur Respir J 2018; 51: 1800692.
Google Scholar | Crossref | Medline7. Travis, WD, Costabel, U, Hansell, DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188: 733–748.
Google Scholar | Crossref | Medline | ISI8. Martinez, FJ, Collard, HR, Pardo, A, et al. Idiopathic pulmonary fibrosis. Nat Rev Dis Primers 2017; 3: 17074.
Google Scholar | Crossref | Medline9. Travis, WD, Hunninghake, G, King, TE, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008; 177: 1338–1347.
Google Scholar | Crossref | Medline10. Rubio-Rivas, M, Royo, C, Simeón, CP, et al. Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 2014; 44: 208–219.
Google Scholar | Crossref | Medline11. Wells, AU, Denton, CP. Interstitial lung disease in connective tissue disease–mechanisms and management. Nat Rev Rheumatol 2014; 10: 728–739.
Google Scholar | Crossref | Medline12. Kolahian, S, Fernandez, IE, Eickelberg, O, et al. Immune mechanisms in pulmonary fibrosis. Am J Respir Cell Mol Biol 2016; 55: 309–322.
Google Scholar | Crossref | Medline13. Rangel-Moreno, J, Hartson, L, Navarro, C, et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006; 116: 3183–3194.
Google Scholar | Crossref | Medline | ISI14. Hoffmann-Vold, AM, Weigt, SS, Saggar, R, et al. Endotype-phenotyping may predict a treatment response in progressive fibrosing interstitial lung disease. Ebiomedicine 2019; 50: 379–386.
Google Scholar | Crossref | Medline15. Chen, H-H, Yong, Y-M, Lin, C-H, et al. Air pollutants and development of interstitial lung disease in patients with connective tissue disease: a population-based case–control study in Taiwan. BMJ Open 2020; 10: e041405.
Google Scholar | Crossref16. Sack, C, Vedal, S, Sheppard, L, et al. Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air–lung study. Eur Respir J 2017; 50: 1700559.
Google Scholar | Crossref | Medline17. Wynn, TA. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339–1350.
Google Scholar | Crossref | Medline | ISI18. Zhang, L, Wang, Y, Wu, G, et al. Macrophages: friend or foe in idiopathic pulmonary fibrosis? Respir Res 2018; 19: 170.
Google Scholar | Crossref | Medline19. Valenzi, E, Bulik, M, Tabib, T, et al. Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease. Ann Rheum Dis 2019; 78: 1379–1387.
Google Scholar | Crossref | Medline20. Reyfman, PA, Walter, JM, Joshi, N, et al. Single-cell transcriptomic analysis of human lung provides insights into the pathobiology of pulmonary fibrosis. Am J Respir Crit Care Med 2019; 199: 1517–1536.
Google Scholar | Crossref | Medline21. Diab, S, Dostrovsky, N, Hudson, M, et al. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects. J Rheumatol 2014; 41: 2179–2185.
Google Scholar | Crossref | Medline22. Dougherty, DH, Kwakkenbos, L, Carrier, ME, et al. The Scleroderma Patient-Centered Intervention Network Cohort: baseline clinical features and comparison with other large scleroderma cohorts. Rheumatology 2018; 57: 1623–1631.
Google Scholar | Crossref | Medline23. Hunzelmann, N, Genth, E, Krieg, T, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology 2008; 47: 1185–1192.
Google Scholar | Crossref | Medline | ISI24. Meyer, OC, Fertig, N, Lucas, M, et al. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis. J Rheumatol 2007; 34: 104–109.
Google Scholar | Medline25. Nihtyanova, SI, Schreiber, BE, Ong, VH, et al. Prediction of pulmonary complications and long-term survival in systemic sclerosis. Arthritis Rheumatol 2014; 66: 1625–1635.
Google Scholar | Crossref | Medline26. Walker, UA, Tyndall, A, Czirják, L, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754–763.
Google Scholar | Crossref | Medline | ISI27. Hoffmann-Vold, AM, Fretheim, H, Halse, AK, et al. Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort. Am J Respir Crit Care Med 2019; 200: 1258–1266.
Google Scholar | Crossref | Medline28. Mango, RL, Matteson, EL, Crowson, CS, et al. Assessing mortality models in systemic sclerosis-related interstitial lung disease. Lung 2018; 196: 409–416.
Google Scholar | Crossref | Medline29. Rotondo, C, Urso, L, Praino, E, et al. Thoracic lymphadenopathy as possible predictor of the onset of interstitial lung disease in systemic sclerosis patients without lung involvement at baseline visit: a retrospective analysis. J Scleroderma Rel Disord 2020; 5: 210–218.
Google Scholar | SAGE Journals30. Tyndall, AJ, Bannert, B, Vonk, M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809–1815.
Google Scholar | Crossref | Medline | ISI31. Guler, SA, Winstone, TA, Murphy, D, et al. Does systemic sclerosis-associated interstitial lung disease burn out? Specific phenotypes of disease progression. Ann Am Thorac Soc 2018; 15: 1427–1433.
Google Scholar | Crossref | Medline32. Bongartz, T, Nannini, C, Medina-Velasquez, YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010; 62: 1583–1591.
Google Scholar | Crossref | Medline33. Carmona, L, González-Alvaro, I, Balsa, A, et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003; 62: 897–900.
Google Scholar | Crossref | Medline34. Koduri, G, Norton, S, Young, A, et al. Interstitial lung disease has a poor prognosis in rheumatoid arthritis: results from an inception cohort. Rheumatology 2010; 49: 1483–1489.
Google Scholar | Crossref | Medline | ISI35. Olson, AL, Swigris, JJ, Sprunger, DB, et al. Rheumatoid arthritis-interstitial lung disease-associated mortality. Am J Respir Crit Care Med 2011; 183: 372–378.
Google Scholar | Crossref | Medline | ISI36. Richman, NC, Yazdany, J, Graf, J, et al. Extraarticular manifestations of rheumatoid arthritis in a multiethnic cohort of predominantly Hispanic and Asian patients. Medicine 2013; 92: 92–97.
Google Scholar | Crossref | Medline | ISI37. Hyldgaard, C, Hilberg, O, Pedersen, AB, et al. A population-based cohort study of rheumatoid arthritis-associated interstitial lung disease: comorbidity and mortality. Ann Rheum Dis 2017; 76: 1700–1706.
Google Scholar | Crossref | Medline38. Kim, EJ, Collard, HR, King, TE Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009; 136: 1397–1405.
Google Scholar | Crossref | Medline | ISI39. Chen, J, Shi, Y, Wang, X, et al. Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease. Clin Dev Immunol 2013; 2013: 406927.
Google Scholar | Crossref | Medline40. Kelly, CA, Saravanan, V, Nisar, M, et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics–a large multicentre UK study. Rheumatology 2014; 53: 1676–1682.
Google Scholar | Crossref | Medline | ISI41. Sparks, JA, He, X, Huang, J, et al. Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis–associated interstitial lung disease: a prospective cohort study. Arthritis Rheumatol 2019; 71: 1472–1482.
Google Scholar | Crossref | Medline42. Hyldgaard, C, Ellingsen, T, Hilberg, O, et al. Rheumatoid arthritis-associated interstitial lung disease: clinical characteristics and predictors of mortality. Respiration 2019; 98: 455–460.
Google Scholar | Crossref | Medline43. Raimundo, K, Solomon, JJ, Olson, AL, et al. Rheumatoid arthritis–interstitial lung disease in the United States: prevalence, incidence, and healthcare costs and mortality. J Rheumatol 2019; 46: 360–369.
Google Scholar | Crossref | Medline44. Chen, IJ, Jan Wu, YJ, Lin, CW, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 2009; 28: 639–646.
Google Scholar | Crossref | Medline | ISI45. Kang, EH, Lee, EB, Shin, KC, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology 2005; 44: 1282–1286.
Google Scholar | Crossref | Medline | ISI46. Marie, I, Hachulla, E, Chérin, P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002; 47: 614–622.
Google Scholar | Crossref | Medline47. Lilleker, JB, Vencovsky, J, Wang, G, et al. The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 2018; 77: 30–39.
Google Scholar | Crossref |